Table 4 Two-dimensional and three-dimensional echocardiographic parameters measured at pre- and 6 months post-surgery
Variable | Pre-surgery | Sixth month | P Within Group |
|---|---|---|---|
TAPSE (mm) | |||
Group 1 | 24.5 ± 4.8 | 14.9 ± 3 | < 0.0001 |
Group 2 | 27.4 ± 5.3 | 19.3 ± 4.2 | 0.0003 |
Group 3 | 23.5 ± 4 | 21.5 ± 4.1 | 0.013 |
SPAP (mmHg) | |||
Group 1 | 33.9 ± 4.8 | 25.7 ± 2.9 | < 0.0001 |
Group 2 | 32.3 ± 5.1 | 28.3 ± 6.5 | 0.054 |
Group 3 | 34.9 ± 8.1 | 25.2 ± 3.1 | 0.049 |
RVEDV (ml) | |||
Group 1 | 111.7 ± 42.8 | 93.1 ± 26.2 | 0.016 |
Group 2 | 88.8 ± 26.1 | 72.2 ± 21.3 | 0.002 |
Group 3 | 116.5 ± 19.8 | 105.2 ± 20.6 | 0.039 |
RVESV (ml) | |||
Group 1 | 43.4 ± 22.5 | 39.2 ± 13.6 | 0.244 |
Group 2 | 34.7 ± 11.7 | 29.2 ± 9.2 | 0.048 |
Group 3 | 48.5 ± 11.6 | 41 ± 9 | 0.005 |
3D RVEF (%) | |||
Group 1 | 62.2 ± 8.9 | 58.2 ± 5.4 | 0.021 |
Group 2 | 60.5 ± 8.2 | 59.5 ± 6.9 | 0.579 |
Group 3 | 58.5 ± 6.1 | 60.7 ± 6.8 | 0.207 |
3D RVSV (ml) | |||
Group 1 | 68.3 ± 23.9 | 53.9 ± 13.9 | 0.004 |
Group 2 | 54.1 ± 18.8 | 43 ± 14.1 | 0.0039 |
Group 3 | 68 ± 13.1 | 64.1 ± 15.9 | 0.349 |